Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.57 USD | -0.87% | +3.74% | +11.04% |
Apr. 17 | JonesTrading Starts Achieve Life Sciences With Buy Rating, $20 Price Target | MT |
Mar. 28 | Transcript : Achieve Life Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.04% | 158M | |
+2.42% | 42.75B | |
+47.70% | 41.61B | |
+12.09% | 41.34B | |
-8.83% | 26.59B | |
+6.84% | 25.49B | |
-22.84% | 18.12B | |
+30.41% | 12.24B | |
-2.08% | 11.76B | |
+9.14% | 11B |
- Stock Market
- Equities
- ACHV Stock
- News Achieve Life Sciences, Inc.
- Oppenheimer Adjusts Achieve Life Sciences Price Target to $18 From $21, Maintains Outperform Rating